These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 12014019

  • 21. Standardization of hepatitis C virus RNA quantification.
    Pawlotsky JM, Bouvier-Alias M, Hezode C, Darthuy F, Remire J, Dhumeaux D.
    Hepatology; 2000 Sep; 32(3):654-9. PubMed ID: 10960464
    [Abstract] [Full Text] [Related]

  • 22. A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C.
    Martinot-Peignoux M, Boyer N, Le Breton V, Le Guludec G, Castelnau C, Akremi R, Marcellin P.
    Hepatology; 2000 Mar; 31(3):726-9. PubMed ID: 10706564
    [Abstract] [Full Text] [Related]

  • 23. Changes in serum levels of hepatitis C virus genotype 1b monitored by real-time quantitative polymerase chain reaction as a predictor of long term response to interferon-alpha treatment.
    Enomoto M, Nishiguchi S, Shiomi S, Tanaka M, Yokogawa T, Fukuda K, Ueda T, Tamori A, Habu D, Takeda T, Yano Y, Otani S.
    Am J Gastroenterol; 2002 Feb; 97(2):420-6. PubMed ID: 11866282
    [Abstract] [Full Text] [Related]

  • 24. Consistency of quantitation of HCV genotype 4 from egypt across three HCV-RNA amplification assays.
    El Sharkawi FZ, Chudy M, Hanschmann KM, Kress J, Nübling CM.
    J Med Virol; 2008 Dec; 80(12):2086-91. PubMed ID: 19040283
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the invader assay for genotyping hepatitis C virus.
    Germer JJ, Majewski DW, Yung B, Mitchell PS, Yao JD.
    J Clin Microbiol; 2006 Feb; 44(2):318-23. PubMed ID: 16455877
    [Abstract] [Full Text] [Related]

  • 26. [Serum levels of HCV-RNA determined by branched DNA (bDNA) probe assay in chronic hepatitis C: method and clinical significance on interferon (IFN) therapy].
    Osada T, Iwabuchi S, Takatori M, Murayama M, Iino S.
    Nihon Rinsho; 1994 Jul; 52(7):1747-53. PubMed ID: 7521414
    [Abstract] [Full Text] [Related]

  • 27. Host and viral characteristics affecting the response to interferon therapy in chronic hepatitis C.
    Laurent-Puig P, Dussaix E, Altman C, Laval C, Stuyver L, Wilber JC, Babany G, Chopineau S, Bedossa P, Brocheriou I.
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):335-40. PubMed ID: 7541297
    [Abstract] [Full Text] [Related]

  • 28. Real-time multiplex PCR assay to quantify hepatitis C virus RNA in peripheral blood mononuclear cells.
    Pugnale P, Latorre P, Rossi C, Crovatto K, Pazienza V, Gottardi AD, Negro F.
    J Virol Methods; 2006 May; 133(2):195-204. PubMed ID: 16384611
    [Abstract] [Full Text] [Related]

  • 29. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
    Naito M, Matsui A, Inao M, Nagoshi S, Nagano M, Ito N, Egashira T, Hashimoto M, Mishiro S, Mochida S, Fujiwara K.
    J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
    [Abstract] [Full Text] [Related]

  • 30. Attachment of hepatitis C virus to cultured cells: a novel predictive factor for successful interferon therapy.
    Kimura Y, Hayashida K, Ishibashi H, Niho Y, Akazawa K, Yanagi Y.
    J Med Virol; 1998 Sep; 56(1):25-32. PubMed ID: 9700629
    [Abstract] [Full Text] [Related]

  • 31. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H, Ogawa H, Kuroda T, Yamamoto M, Enomoto H, Kishima Y, Yoshida K, Ito H, Matsuda M, Noguchi S.
    Hepatogastroenterology; 2002 Sep; 49(47):1373-6. PubMed ID: 12239945
    [Abstract] [Full Text] [Related]

  • 32. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
    Gelderblom HC, Menting S, Beld MG.
    Antivir Ther; 2006 Sep; 11(1):95-103. PubMed ID: 16518965
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
    Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H.
    J Med Virol; 2008 Aug; 80(8):1363-9. PubMed ID: 18551610
    [Abstract] [Full Text] [Related]

  • 34. A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1B.
    Murayama M, Katano Y, Nakano I, Ishigami M, Hayashi K, Honda T, Hirooka Y, Itoh A, Goto H.
    J Med Virol; 2007 Jan; 79(1):35-40. PubMed ID: 17133546
    [Abstract] [Full Text] [Related]

  • 35. [Predicting factors for the response to interferon therapy against hepatitis C virus infection: HCV genotyping].
    Yoshioka K, Kakumu S.
    Rinsho Byori; 1994 Oct; 42(10):1010-4. PubMed ID: 7527870
    [Abstract] [Full Text] [Related]

  • 36. Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN-resistant cases with hepatocyte steatosis.
    Akuta N, Suzuki F, Suzuki Y, Sezaki H, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H.
    J Med Virol; 2005 Apr; 75(4):550-8. PubMed ID: 15714492
    [Abstract] [Full Text] [Related]

  • 37. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML, Chuang WL, Dai CY, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Tsai SL, Kuo HT.
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H.
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [Abstract] [Full Text] [Related]

  • 40. [Genotyping and the quantification of hepatitis C virus by the melting curves in light cycler].
    Takemura M, Fujigaki H, Takahashi K, Saito K, Fujii H, Wada H, Seishima M.
    Rinsho Byori; 2004 Feb; 52(2):167-71. PubMed ID: 15027322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.